Evidence map›Paper›PMID 30617094›Full record

ArticleAntimicrobial agents and chemotherapy2019

Adjuvant β-Lactam Therapy Combined with Vancomycin for Methicillin-Resistant

Thomas J Dilworth, Anthony M Casapao, Omar M Ibrahim, David M Jacobs, Dana R Bowers, Nicholas D Beyda, Renee-Claude Mercier

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. An Achilles' heel for methicillin-resistantAntimicrobial agents and chemotherapy · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Adjunctive β-lactams forTherapeutic advances in infectious disease
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 1 country.

Thomas J DilworthAurora Health Care, Department of Pharmacy Services, Milwaukee, Wisconsin, USA thomas.dilworth@aurora.org.
Anthony M CasapaoUniversity of Florida College of Pharmacy, Jacksonville, Florida, USA.
Omar M IbrahimIndependent Researcher, Gainesville, Florida, USA.
David M JacobsUniversity at Buffalo School of Pharmacy and Pharmaceutical Sciences, Buffalo, New York, USA.ORCID 0000-0001-9240-7067
Dana R BowersWashington State University College of Pharmacy and Pharmaceutical Sciences, Yakima, Washington, USA.
Nicholas D BeydaUniversity of Houston College of Pharmacy, Houston, Texas, USA.
Renee-Claude MercierUniversity of New Mexico College of Pharmacy, Albuquerque, New Mexico, USA.
Aurora Health Care · USUniversity at Buffalo, State University of New York · USUniversity of Florida · USUniversity of Houston · USUniversity of New Mexico · USWashington State University · US

Funding

Institutional Career DevelopmentKL2TR001413 · NCATS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI DUBOCOVICH, MARGARITA L · 2015 to 2024
$4.2M
NCATS NIH HHS KL2 TR001413
6 · The paper itself

Abstract

We analyzed the impact of vancomycin (VAN) combined with adjuvant β-lactam therapy (Combo) on persistent (≥5 days) methicillin-resistant

Indexed as

Acute Kidney InjuryAnti-Bacterial AgentsBacteremiabeta-LactamsDrug Therapy, CombinationFemaleHumansMaleMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsMiddle AgedObservational Studies as TopicRetrospective StudiesStaphylococcal InfectionsTreatment OutcomeVancomycinAnti-Bacterial Agentsbeta-LactamsVancomycinbacteremiacombination therapymethicillin-resistant Staphylococcus aureusvancomycinβ-lactam

Identifiers

PMID30617094
PMCPMC6395910
OpenAlexW2909118206

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.